发明名称 CLONIDINE PERCUTANEOUS ADMINISTRATION MATRIX
摘要 PURPOSE:To obtain the titled preparation highly releasing clonidine, improving bioavailability, capable of being administered for a long period, by using a matrix containing a specific elastic polymer, a water absorbing high polymer, natural gum substance and a higher fatty acid ester. CONSTITUTION:1-20wt.% especially 5-12wt.% clonidine is added to a matrix containing (A) 5-20wt.% elastic polymer of (A-B)nX or (A-B)n-A type [A is monovinyl-substituted aromatic compound polymer block; B is conjugated diolefin copolymer block; n is 3-7; X is residue of polyfunctional compound to which n polymer chains (A-B) are bonded] as a matrix base, (B) 1-7wt.% water absorbing high polymer such as water-soluble polymer to which a crosslinking bond of light degree is introduced, (C) 0.5-5wt.% natural gum substance preferably karaya gum or guar gum and (D) 0.1-4wt.% higher fatty acid ester as essential components.
申请公布号 JPS63203615(A) 申请公布日期 1988.08.23
申请号 JP19870033461 申请日期 1987.02.18
申请人 HISAMITSU PHARMACEUT CO INC 发明人 NAKAGAWA AKIRA;HIRANO MUNEHIKO;YAMAGUCHI HISASHI;MUKAI KATSUYA;KUBOTA YUSUKE
分类号 A61K9/70;A61K31/415;A61P9/12;C07D233/50 主分类号 A61K9/70
代理机构 代理人
主权项
地址